Systemic Immunity Is Required for Effective Cancer Immunotherapy
Published Jan 26, 2017 · M. Spitzer, Yaron Carmi, Nathan E. Reticker-Flynn
Cell
Q1 SJR score
721
Citations
19
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawaySystemic immune responses, coordinated across tissues, are crucial for effective cancer immunotherapy, with peripheral CD4 T cells playing a key role in tumor rejection.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
···
···
···
···